Targeted mutagenesis by homologous recombination in D. melanogaster

  1. Yikang S. Rong1,2,4,
  2. Simon W. Titen1,2,
  3. Heng B. Xie1,2,
  4. Mary M. Golic1,2,
  5. Michael Bastiani1,
  6. Pradip Bandyopadhyay1,
  7. Baldomero M. Olivera1,
  8. Michael Brodsky3,5,
  9. Gerald M. Rubin3, and
  10. Kent G. Golic1,2,6
  1. 1Department of Biology, University of Utah, Salt Lake City, Utah 84112, USA; 2Stowers Institute for Medical Research, Kansas City, Missouri 64110, USA; 3Howard Hughes Medical Institute, Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA

Abstract

We used a recently developed method to produce mutant alleles of five endogenous Drosophila genes, including the homolog of thep53 tumor suppressor. Transgenic expression of the FLP site-specific recombinase and the I-SceI endonuclease generates extrachromosomal linear DNA molecules in vivo. These molecules undergo homologous recombination with the corresponding chromosomal locus to generate targeted alterations of the host genome. The results address several questions about the general utility of this technique. We show that genes not near telomeres can be efficiently targeted; that no knowledge of the mutant phenotype is needed for targeting; and that insertional mutations and allelic substitutions can be easily produced.

Keywords

Footnotes

  • Present addresses: 4Laboratory of Molecular Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; 5Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, MA 01655, USA.

  • 6 Corresponding author.

  • E-MAIL kgg{at}stowers-institute.org; FAX (816) 926-2065.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.986602.

    • Received February 21, 2002.
    • Accepted May 3, 2002.
| Table of Contents

Life Science Alliance